Connect with us

Health

FG Okays N263m for Arabic Gum Seedlings

Published

on

FG Okays N263m for Arabic Gum Seedlings

FG Okays N263m for Arabic Gum Seedlings

By Modupe Gbadeyanka

The sum of N263 million has been approved by the Federal Government for the production of Arabic gum seedlings for Nigerian farmers and for export.

Minister of Agriculture, Mr Audu Ogbeh, told journalists on Wednesday that the money was approved for three research institutions to carry out this assignment.

Mr Ogbeh, while addressing newsmen at the end of the Federal Executive Council (FEC) meeting presided over by the Acting President, Mr Yemi Osinbajo, in Abuja, noted that similar efforts were on to boost cassava production in the country.

He emphasised that in 2016, Nigeria earned as much as $43 million from export of Arabic gum, also known as acacia gum, and that more would be earned with increased production, especially now that the commodity was in high demand in 17 other countries.

Arabic gum is a natural gum consisting of the hardened sap of various species of the acacia tree. It was originally collected from Acacia nilotica which was called the “gum arabic tree” in the present day.

It is predominantly collected from two related species, namely Acacia senegal and Vachellia (Acacia) seyal.

Producers harvest the gum commercially from wild trees, mostly in Sudan (80%) and throughout the Sahel, from Senegal to Somalia—though it is historically cultivated in Arabia and West Asia.

Among its usefulness are for pain relief and irritation, healing of wound, soothing of coughs and sore throats, oral health promotion, good source of fibre, body fat reduction and more.

Modupe Gbadeyanka is a fast-rising journalist with Business Post Nigeria. Her passion for journalism is amazing. She is willing to learn more with a view to becoming one of the best pen-pushers in Nigeria. Her role models are the duo of CNN's Richard Quest and Christiane Amanpour.

2 Comments

2 Comments

Leave a Reply

Health

mPharma Launches Programme to Tackle Hypertension in Nigeria, Others 

Published

on

Hypertension

By Adedapo Adesanya

mPharma has launched the Hypertension Test and Treat programme (HTT) to support the prevention and control of hypertension in Africa.

Heart disease is one of the greatest causes of premature death in Africa. The World Health Organization (WHO) estimates that the prevalence of hypertension is highest in the African region, with about 46 per cent of adults aged 25 years and older being hypertensive compared to 35 per cent in the Americas and other HIC and 40 per cent elsewhere in the world.

The HTT programme will be delivered through the company’s network of mutti pharmacies in Nigeria, Ghana, Kenya, and Zambia, with plans to expand the service to other countries.

The programme would aim to identify different classes of people, those at risk for hypertension, those who are about to develop hypertension and those who are already living with hypertension. The objectives would be to prevent, detect, and control the conditions.

Speaking at the launch of the programme in Nigeria, Dr Olagoke Ewedairo, VP of Health Services at mPharma, said the hypertension test and treat program is a service which aims to promote the early detection of hypertension, prompt treatment and prevention of complications such as hypertensive heart disease, kidney failure etc. which are on the rise despite being preventable.

The service includes a private consultation to review your medical history and current medications, determine your cardiovascular risk level and provide tailored lifestyle modification strategies to improve your health and wellbeing. In addition, a range of diagnostic tests would be available; all of these are to ensure you have a healthy heart.

On his part, Dr Hafeez Oluwa, the Global Primary Care Manager at mPharma, said that the company is taking a different approach to dealing with hypertension, going further than just helping people who have already developed the condition to identify people who are at risk of hypertension and collaborating with them to prevent the development of the disease.

“The passive approach has just led to numbers rising exponentially. We need to think more about primary prevention as we deal with hypertension with health promotion. If we start implementing lifestyle changes at an earlier stage, we may prevent more diagnoses of hypertension”, he said, speaking at the launch.

The programme has been rolled out in stages, the first stage was using the ongoing diabetes programme at mPharma, Diabetes Test and Treat, which has helped over 3000 patients achieve optimal glycemic control, become more aware of their risk of developing hypertension and helping those who have been diagnosed be more adherent to their medication.

The second stage was identifying people living with hypertension around our communities and deploying health education and coaching to help them control their blood pressure. Mr Dominic, a beneficiary of the program, said he was happy with the initiative as he got more insights into some of the things he had been doing that were preventing him from getting better. He wanted mPharma to do more to make sure many more people like him have access to this initiative.

The programme, in its final form, will include more people in its target audience, including people identified as being at risk of hypertension. It would be available in Kenya as a subscription service for purchase through mPharma mutti pharmacies and in subsequent months in other countries. It aligns with mPharma’s vision of providing accessible and affordable care to patients in vulnerable communities across Africa by transforming its mutti pharmacies into primary healthcare centres.

The hypertension test and treat service launches at select mutti pharmacies in Nigeria are effective today. Patients can visit any of mPharma mutti pharmacies to check their blood pressure for free and discuss their eligibility program.

mPharma plans to expand the hypertension test and treatment service to all 500 locations of mutti branches over time as the company’s ultimate aim is to put every African in good health and to contribute their quota to making universal healthcare coverage available to all.

Continue Reading

Health

Stanbic IBTC Pushes for Innovative Financing Solutions for Healthcare

Published

on

innovative financing solutions

By Modupe Gbadeyanka

The healthcare industry in Nigeria can compete with others in advanced countries if stakeholders work together to create innovative financing solutions.

The Head of Specialised Sectors at Stanbic IBTC Bank, Ms Jane Ike-Okoli, said the market is big enough to attract more investors.

A few days ago, Business Post reported that a global research firm, Agusto & Co, projected that an increased foreign interest would drive growth in Nigeria’s healthcare system, especially through the acquisition and establishment of health facilities in the medium term, helping to bridge the healthcare infrastructure deficit estimated at $82 million.

For Ms Ike-Okoli, this goal can be achieved as Nigeria is Africa’s largest healthcare market. She said the country only needs an effective collaboration among stakeholders to boost the sector.

Speaking during the panel session at the Medic West Africa Conference, Ms Ike-Okoli argued that effective collaboration between the financial industry and healthcare organisations was key to advancing Nigeria’s health sector.

She also mentioned that the sector is yearning for innovative financing solutions to address the nuances of lending to healthcare businesses.

“Nigeria is Africa’s largest healthcare market, and despite this, we have inadequate healthcare infrastructure, which gives rise to weakened health systems.

“It is in response to this that Stanbic IBTC has decided to partner with key players in the healthcare sector to improve access to healthcare finance and provide robust yet flexible funding options for healthcare businesses and providers.

“Our healthcare solutions are tailor-made for players in the sector who need working capital to expand healthcare operations, acquire medical equipment, facilitate medical research, and grow their healthcare businesses.

“One of such solutions is the recently launched unsecured short-term loan with a 12-month tenor, which is aimed at directly supporting providers with funds to improve their offerings and, by extension, grow the healthcare sector in Nigeria,” she stated.

Other panellists featured at the event included Dr Folabi Ogunlesi, Managing Partner Vesta Healthcare; Dr Idorenyin Oladiran, Medical Consultant, Human Resources, MTN Nigeria; Dr Leke Oshunniyi, CEO, Health and Managed Care Association of Nigeria (HMCAN) and Professor Akin Abayomi, Commissioner of Health, Lagos State.

Continue Reading

Health

Pharmaceutical Company Introduces Affordable Blood Tonic for Nigerians

Published

on

Fejeron Blood Tonic

By Aduragbemi Omiyale

The harsh economy in Nigeria caused by high prices of items amid low purchasing power has made it difficult for Nigerians to afford the basic needs of life, especially drugs to replenish their body system.

As a result, the rate of suicide triggered by depression and others has increased. Also, the number of people falling sick in the country has skyrocketed.

But things may soon change for the better as a pharmaceutical firm, Sterling Biopharma Limited, has introduced a new product called Fejeron Blood Tonic into the Nigerian market to support the country’s about 66.8 per cent economically active population.

Fejeron Blood Tonic contains iron, Vitamin B12 and folic acid, all essential components that help to facilitate adequate blood supply and replenishment to the body with vital vitamins while enabling a strong immune system.

“Fejeron Blood Tonic is the latest proof of our commitment to this mission. Despite its premium quality, Fejeron, at the moment, is one of the most affordable blood tonics you will find in the Nigerian pharma market, and this is deliberate. All Nigerians should be able to take care of themselves,” the chief operating officer of Sterling Biopharma, Mr Adebayo Adepoju, said at the unveiling of the product in Lagos on Thursday, September 15.

He said the drug was formulated due to the nature of stress and fatigue that Nigerians encounter daily, which requires that their physical and mental well-being is well supported to function at its best.

“At Sterling Biopharma, we believe that everyone deserves to be able to buy simple prescription drugs without breaking the bank. This is why from the moment we entered the Nigerian market. With our wide range of products, we have made our intentions clear, and that is to make quality pharmaceutical products affordable for all Nigerians,” he stated.

Since its market introduction, Fejeron has quickly become one of the well-sought-after new brands in the pharmaceutical category. The Product Manager, Olumide Ogunremi, linked the warm embrace of the product to its quality and appeal to the needs of Nigerians.

“The quick acceptance of Fejeron Blood Tonic in Nigeria is not surprising. The enthusiasm to try out the product and the return purchases across the biggest pharmaceutical markets in Nigeria validate the quality of the product and timeliness of its emergence.”

On what makes Fejeron Blood Tonic unique, Mr Ogunremi promised that both the young and old would love the taste of Fejeron, adding that extra effort has also been put into ensuring that the product has fewer chances of causing common side effects like metallic after-taste, staining of the teeth; constipation, diarrhoea, nausea and others.

Continue Reading

Latest News on Business Post

Like Our Facebook Page

%d bloggers like this: